PHASE 3 ALCANZA STUDY OF BRENTUXIMAB VEDOTIN (BV) OR PHYSICIAN'S CHOICE (PC) OF METHOTREXATE (MTX) OR BEXAROTENE (BEX) IN CD30-POSITIVE CUTANEOUS T-CELL LYMPHOMA (CTCL): NUMBER NEEDED TO TREAT ANALYSIS

E. Zagadailov,H. M. Prince, S. Whittaker,S. Horwitz, M. Duvic,Y. Kim, R. Dummer, J. Scarisbrick,P. Quaglino,P. L. Zinzani,P. Wolter, L. Geskin,J. Feliciano,Y. Wang,M. C. Palanca-Wessels,A. Gautam,Y. Zhu,H. -M. Lin,Y. Liu,M. Little, M. R. Dalal

HAEMATOLOGICA(2017)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要